epocrates

Trending Patient News: Week of February 23, 2025

February 27, 2026

Keeping you a step ahead is our priority. That's why we've gathered some of the top stories your patients might be seeing. Here are this week's highlights:

Novo Nordisk to slash Ozempic and Wegovy list prices by up to 50% for 2027

(CNN)—Novo Nordisk plans major price cuts for Ozempic and Wegovy starting in 2027, a move expected to improve access to GLP‑1 medications amid soaring demand. Read more

Recent studies challenge Kennedy's claims about vaccines, Tylenol and antidepressants

(NBC News)—New research disputes several health claims promoted by Kennedy, reaffirming strong evidence supporting vaccine safety and clarifying misconceptions about Tylenol and antidepressant use. Read more

Plastic Eating for weight loss? What is the viral China trend and all about its health risk

(The Economic Times)—A viral trend involving eating plastic‑like synthetic substances for weight loss is raising alarm among health experts, who warn of severe toxicity and gastrointestinal harm. Read more

The ‘Last 20 Pounds’ Pill: The new Wegovy is for people who never thought they would use a GLP‑1

(The Cut)—A new lower‑dose Wegovy formulation is gaining traction among people seeking modest weight loss, expanding GLP‑1 use beyond patients with obesity. Read more

‘It’s ruined my life’: Hundreds tell BBC how medication triggered gambling and other addictions

(BBC)—Hundreds report compulsive gambling and other harmful behaviors linked to certain prescribed medications, prompting calls for stronger warnings and clinician awareness. Read more

Content availability may vary; some sources may require payment or registration.

Any views, thoughts, and opinions expressed in these articles are solely that of the publication and/or author and do not reflect the views, opinions, policies, or position of epocrates and athenahealth.